Baird Medical Investment Holdings (BDMDW) Change in Accured Expenses (2024 - 2025)
Baird Medical Investment Holdings' quarterly Change in Accured Expenses came in at $2.6 million in Q2 2025, up 4.17% quarter-over-quarter from $2.5 million in Q4 2024.
Baird Medical Investment Holdings has reported Change in Accured Expenses for 2 years, with the latest figure at $2.6 million in Q2 2025.
- For the quarter ending Q2 2025, Change in Accured Expenses changed N/A year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2025 stood at $2.6 million (changed N/A YoY), and the FY2025 full-year result was -$450913.0, down 117.91% from the prior year.
- Change in Accured Expenses for Q2 2025 stood at $2.6 million, up from $2.5 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.6 million in Q2 2025, with the low at $2.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Baird Medical Investment Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Dec 31, 2024 | 2.52 Mn |